U.S. market Closed. Opens in 6 hours 5 minutes

ONTX | Onconova Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue226.00K226.00K226.00K231.00K2.18M1.23M787.00K5.55M11.46M800.00K4.75M46.19M1.49M
Cost of Revenue-226.00B14.00K14.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit226.00B212.00K212.00K231.00K2.18M1.23MN/AN/AN/A800.00K4.75M46.19MN/A
Operating Expenses20.52M19.85M16.72M25.22M23.88M24.51M26.52M29.25M35.43M64.54M66.97M68.47MN/A
Selling, General & Admin9.09M8.45M9.43M8.33M8.35M7.59M7.41M9.18M9.53M15.12M16.79MN/A6.44M
Research & Development11.43M11.41M7.30M16.90M15.54M16.92M19.12M20.07M25.89M49.42M50.18M52.76M22.62M
Other Operating Expenses1.35M663.00K12.00K48.00K143.00K1.15MN/AN/AN/AN/AN/A15.71MN/A
Operating Income-20.30M-19.63M-16.50M-24.99M-21.70M-23.28M-25.74M-23.70M-23.97M-63.74M-62.22M-22.28M-27.57M
Other Expenses / Income1.35M663.00K333.00K-160.00K206.00K2.75M1.66M4.05M-35.00K-32.00K101.00K-7.63M1.28M
Before Tax Income-18.95M-18.96M-16.16M-25.15M-21.49M-20.53M-24.08M-19.65M-24.01M-63.78M-62.12M-29.91M-26.29M
Income Tax ExpensesN/A-663.00K-335.00K4.00K10.00K-124.00K13.00K14.00K16.00K19.00K435.00KN/AN/A
Net Income-18.95M-18.30M-15.83M-25.16M-21.50M-20.57M-24.09M-19.67M-23.98M-63.68M-62.54M-29.91M-26.29M
Interest ExpensesN/A-14.00KN/AN/AN/AN/AN/AN/AN/A2.00K4.00K8.61M19.00K
Basic Shares Outstanding20.99M20.91M16.83M11.60M958.97K274.94K40.00K19.67K10.11K9.62K4.71K5.63K6.86K
Diluted Shares Outstanding20.99M20.91M16.83M11.60M958.97K274.94K40.00K19.67K10.11K9.62K4.71K5.63K6.86K
EBITDA-20.28M-19.63M-16.82M-24.79M-21.76M-24.88M-23.99M-19.56M-23.81M-63.23M-61.66M-20.98M-25.96M
EBITDA Margin-8,974.34%-8,684.51%-7,441.15%-10,729.44%-996.89%-2,025.98%-3,048.41%-352.63%-207.86%-7,903.38%-1,297.24%-45.43%-1,745.73%
EBIT-18.95M-18.98M-16.16M-25.15M-21.49M-20.70M-24.08M-19.65M-23.96M-63.66M-62.10M-21.30M-26.27M
EBIT Margin-8,384.07%-8,397.35%-7,151.77%-10,888.74%-984.56%-1,685.42%-3,059.59%-354.36%-209.17%-7,957.63%-1,306.63%-46.12%-1,766.98%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙